Paul Riley

3 POSTS 0 COMMENTS
Paul is Medical Affairs Director at Glasshouse Health. He is an experienced medical affairs professional with expertise in bridging the gaps between healthcare companies, patients, and the medical community. Paul works with pharma companies and technology companies, and specialises in the evaluation and development of effective digital technology strategies and procurement planning.

Latest articles

EC grants marketing authorisation for breast cancer treatment Trodelvy

EC grants marketing authorisation for breast cancer treatment Trodelvy

The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Nykode Therapeutics partners with Regeneron to develop innovative vaccines

Nykode Therapeutics partners with Regeneron to develop innovative vaccines

Nykode Therapeutics (formerly Vaccibody) has entered into a collaboration agreement with Regeneron to develop innovative vaccines against cancer and infectious diseases. The agreement includes five...
Image of a woman leaning her head against a window and staring into the mid distance to show new depression treatment options from NICE

New depression treatment options from NICE

The National Institute for Health and Care Excellence (NICE) has created a new menu of treatment options for those living with depression. It is the...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...

Does great brand planning make the difference?

As the hot summer days begin to fade behind us, thoughts start to turn towards next year. Teams are ramping up their planning activities...
New COVID-19 test reduces testing time from 30 minutes to five

New COVID-19 test reduces testing time from 30 minutes to five

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...

Pancreatic Cancer Story: James Dadge

James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription